Drug class · Endocrine & metabolism
GLP-1 receptor agonists Drug Codes & NDCs
Drugs that activate the glucagon-like peptide-1 (GLP-1) receptor. The class includes injectable and oral products; tirzepatide is also listed here because it acts on both the GLP-1 and GIP receptors.
Most-listed names in this class
Ranked by the number of FDA listings, which reflects labelers and package variety — not sales or prescribing.
HCPCS references in Med-Code’s directory
- SemaglutideNo specific codeMed-Code's directory has no drug-specific HCPCS code for semaglutide. Injectable semaglutide is usually self-administered and billed by NDC through a pharmacy benefit. Oral semaglutide tablets are pharmacy-dispensed and have no HCPCS code.
- TirzepatideNo specific codeMed-Code's directory has no drug-specific HCPCS code for tirzepatide. It is usually self-administered and billed by NDC through a pharmacy benefit.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Byettaexenatide | Exenatide 250 ug/mL | InjectionSubcutaneous | AstraZeneca Pharmaceuticals LP | 0310-6512 |
| Byettaexenatide | Exenatide 250 ug/mL | InjectionSubcutaneous | AstraZeneca Pharmaceuticals LP | 0310-6524 |
| Exenatide | Exenatide 250 ug/mL | InjectionSubcutaneous | Amneal Pharmaceuticals LLC | 70121-1685 |
| Exenatide | Exenatide 250 ug/mL | InjectionSubcutaneous | Amneal Pharmaceuticals LLC | 70121-1686 |
| Foundayoorforglipron | Orforglipron calcium .8 mg/1 | Tablet, Film coatedOral | Eli Lilly and Company | 0002-4178 |
| Foundayoorforglipron | Orforglipron calcium 2.5 mg/1 | Tablet, Film coatedOral | Eli Lilly and Company | 0002-4503 |
| Foundayoorforglipron | Orforglipron calcium 5.5 mg/1 | Tablet, Film coatedOral | Eli Lilly and Company | 0002-4794 |
| Foundayoorforglipron | Orforglipron calcium 9 mg/1 | Tablet, Film coatedOral | Eli Lilly and Company | 0002-4803 |
| Foundayoorforglipron | Orforglipron calcium 14.5 mg/1 | Tablet, Film coatedOral | Eli Lilly and Company | 0002-4839 |
| Foundayoorforglipron | Orforglipron calcium 17.2 mg/1 | Tablet, Film coatedOral | Eli Lilly and Company | 0002-4953 |
| Liraglutide | Liraglutide 6 mg/mL | InjectionSubcutaneous | Hikma Pharmaceuticals USA Inc. | 0143-9144 |
| Liraglutide | Liraglutide 6 mg/mL | InjectionSubcutaneous | Teva Pharmaceuticals USA, Inc. | 0480-3667 |
| Liraglutide | Liraglutide 6 mg/mL | Injection, SolutionSubcutaneous | Teva Pharmaceuticals, Inc. | 0480-7250 |
| Liraglutide | Liraglutide 18 mg/3mL | Injection, SolutionSubcutaneous | Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | 14403-3400 |
| Liraglutide | Liraglutide 6 mg/mL | InjectionSubcutaneous | A-S Medication Solutions | 50090-7501 |
| Liraglutide | Liraglutide 6 mg/mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-8145 |
| liraglutide | Liraglutide 6 mg/mL | Injection, SolutionSubcutaneous | Cipla USA Inc. | 69097-910 |
| Liraglutide | Liraglutide 6 mg/mL | Injection, SolutionSubcutaneous | Cipla USA Inc. | 69097-920 |
| Liraglutide | Liraglutide 6 mg/mL | InjectionSubcutaneous | Biocon Pharma Inc. | 70377-094 |
| Liraglutide | Liraglutide 6 mg/mL | Injection, SolutionSubcutaneous | Biocon Pharma Inc. | 70377-095 |
| Liraglutide | Liraglutide 6 mg/mL | InjectionSubcutaneous | Lupin Pharmaceuticals, Inc. | 70748-346 |
| Liraglutide | Liraglutide 6 mg/mL | InjectionSubcutaneous | Meitheal Pharmaceuticals Inc. | 71288-563 |
| Liraglutide | Liraglutide 6 mg/mL | InjectionSubcutaneous | NorthStar Rx LLC | 72603-745 |
| Liraglutide | Liraglutide 6 mg/mL | Injection, SolutionSubcutaneous | Orbicular Pharmaceutical Technologies Private Limited | 81607-018 |
| liraglutide | Liraglutide 6 mg/mL | Injection, SolutionSubcutaneous | Orbicular Pharmaceutical Technologies Private Limited | 81607-019 |